{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:30:04Z","timestamp":1792510204889,"version":"4.5.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic synovitis and joint destruction. To systematically investigate the regulatory relationship between key ferroptosis genes and gut metabolites in RA, this study employed an integrative multi-omics approach combined with machine learning algorithms and single-cell transcriptomic data, identifying and validating GPX3 and MYC as potential critical ferroptosis regulators in RA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and results<\/jats:title><jats:p>First, 16 candidate genes were obtained by intersecting WGCNA, differential expression analysis results, and targets related to ferroptosis and gut microbiota. Following cross-validation with machine learning approaches including LASSO, SVM, and RFE-RF, GPX3 and MYC were ultimately identified as crucial genes. GSVA and GSEA analyses revealed that high expression of GPX3 and MYC was enriched in interferon response and TNFA signaling pathways, while their low expression was associated with fatty acid metabolism and oxidative phosphorylation pathways. Further single-cell RNA sequencing analysis demonstrated that MYC was expressed in multiple immune cell types, particularly in CD4+ T cells and NK cells. Ferroptosis scoring for CD8+ T cells and subsequent cell communication analysis revealed stronger interactions between CD8+ T cells with higher ferroptosis scores and other immune cells through IFN-II and CCL signaling, further intensifying the activation of the inflammatory microenvironment. Additionally, molecular docking analysis of GPX3 and MYC with the gut metabolites Diosgenin and Differentiation-inducing factor 3 (DIF-3) respectively showed that the GPX3-Diosgenin complex had the lowest binding energy, and a 100 ns molecular dynamics simulation was performed on this complex. Results showed good stability of the complex across indicators such as RMSD, RMSF, SASA, and radius of gyration, suggesting that Diosgenin may intervene in ferroptosis and inflammatory injury in RA by binding to and modulating GPX3 function.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study elucidated the multifaceted mechanisms of GPX3 and MYC in RA pathogenesis and preliminarily validated the potential role of gut metabolites in mediating ferroptosis regulation, offering novel theoretical foundations and potential strategies for diagnostic biomarker screening and targeted therapy in RA.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1608262","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T05:47:40Z","timestamp":1752126460000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Integrative multi-omics analysis reveals the interaction mechanisms between gut microbiota metabolites and ferroptosis in rheumatoid arthritis"],"prefix":"10.3389","volume":"16","author":[{"given":"Lifang","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaguo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peifeng","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e070856","DOI":"10.1136\/bmj-2022-070856","article-title":"Therapeutic advances in rheumatoid arthritis","volume":"384","author":"Brown","year":"2024","journal-title":"BMJ"},{"key":"B2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41392-023-01331-9","article-title":"Signaling pathways in rheumatoid arthritis: implications for targeted therapy","volume":"8","author":"Ding","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01525-8","article-title":"Rheumatoid arthritis","volume":"402","author":"Di Matteo","year":"2023","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000001006","article-title":"Autoantibodies in rheumatoid arthritis \u2013 rheumatoid factor, anticitrullinated protein antibodies and beyond","volume":"36","author":"Steiner","year":"2024","journal-title":"Curr Opin Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/imr.13359","article-title":"Gut microbiota as a sensor of autoimmune response and treatment for rheumatoid arthritis","volume":"325","author":"Lamba","year":"2024","journal-title":"Immunol Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.18632\/aging.203641","article-title":"Analysis of gut microbiota and metabolites in patients with rheumatoid arthritis and identification of potential biomarkers","volume":"13","author":"Chen","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1126\/science.1241165","article-title":"The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis","volume":"341","author":"Smith","year":"2013","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1152\/physrev.00031.2024","article-title":"Ferroptosis: when metabolism meets cell death","volume":"105","author":"Conrad","year":"2024","journal-title":"Physiol Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1260839","article-title":"Ferroptosis as an emerging target in rheumatoid arthritis","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103255","article-title":"Inhibition of ferroptosis rescues M2 macrophages and alleviates arthritis by suppressing the HMGB1\/TLR4\/STAT3 axis in M1 macrophages","volume":"75","author":"Feng","year":"2024","journal-title":"Redox Biol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.119160","article-title":"Jingfang Granules alleviates the lipid peroxidation induced ferroptosis in rheumatoid arthritis rats by regulating gut microbiota and metabolism of short chain fatty acids","volume":"339","author":"Wang","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.149106","article-title":"Ferroptosis Induces gut microbiota and metabolic dysbiosis in Collagen-Induced arthritis mice via PAD4 enzyme","volume":"936","author":"Zhu","year":"2025","journal-title":"Gene"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110885","article-title":"BzATP reverses ferroptosis-induced gut microbiota disorders in collagen-induced arthritis mice","volume":"124","author":"Ma","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae1002","article-title":"gutMGene v2.0: an updated comprehensive database for target genes of gut microbes and microbial metabolites","volume":"53","author":"Qi","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5575479","article-title":"Biological anti-TNF-\u03b1 Therapy and markers of oxidative and carbonyl stress in patients with rheumatoid arthritis","volume":"2021","author":"\u0160te\u0148ov\u00e1","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203610","article-title":"JNK-dependent downregulation of FoxO1 is required to promote the survival of fibroblast-like synoviocytes in rheumatoid arthritis","volume":"74","author":"Grabiec","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114019","article-title":"SLC7A11 suppresses pyroptosis to alleviate rheumatoid arthritis development by modulating the IL-17 pathway","volume":"147","author":"Chen","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/e23101348","article-title":"Sparse estimation strategies in linear mixed effect models for high-dimensional data application","volume":"23","author":"Opoku","year":"2021","journal-title":"Entropy Entropy (Basel)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00441-023-03816-z","article-title":"The benefits and pitfalls of machine learning for biomarker discovery","volume":"394","author":"Ng","year":"2023","journal-title":"Cell Tissue Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.21873\/cgp.20063","article-title":"Applications of support vector machine (SVM) learning in cancer genomics","volume":"15","author":"Huang","year":"2018","journal-title":"Cancer Genomics Proteom"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/biom14060689","article-title":"Insights into the role of glutathione peroxidase 3 in non-neoplastic diseases","volume":"14","author":"Zhang","year":"2024","journal-title":"Biomol Biomol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13075-023-03043-5","article-title":"Glutathione peroxidase 3 is a novel clinical diagnostic biomarker and potential therapeutic target for neutrophils in rheumatoid arthritis","volume":"25","author":"Chen","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"B24","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1186\/s12967-023-04432-9","article-title":"Glutathione Peroxidase 3 induced mitochondria-mediated apoptosis via AMPK\/ERK1\/2 pathway and resisted autophagy-related ferroptosis via AMPK\/mTOR pathway in hyperplastic prostate","volume":"21","author":"Li","year":"2023","journal-title":"J Transl Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S499345","article-title":"Programmed cell death in rheumatoid arthritis","volume":"18","author":"Tong","year":"2025","journal-title":"J Inflammation Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-008-1356-5","article-title":"Serum selenium and glutathione peroxidase-3 activity: biomarkers of systemic inflammation in the critically ill","volume":"35","author":"Manzanares","year":"2009","journal-title":"Intensive Care Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.1038\/s41467-022-32368-z","article-title":"MYC sensitises cells to apoptosis by driving energetic demand","volume":"13","author":"Edwards-Hicks","year":"2022","journal-title":"Nat Commun"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109328","article-title":"Acid sensor ASIC1a induces synovial fibroblast proliferation via Wnt\/\u03b2-catenin\/c-Myc pathway in rheumatoid arthritis","volume":"113","author":"Xu","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1002\/mco2.219","article-title":"Osthole regulates N6-methyladenosine-modified TGM2 to inhibit the progression of rheumatoid arthritis and associated interstitial lung disease","volume":"4","author":"Lin","year":"2023","journal-title":"Med Comm"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1976","article-title":"Metabolic regulation of osteoclast differentiation and function","volume":"28","author":"Indo","year":"2013","journal-title":"J Bone Miner Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102903","article-title":"Autoantibodies targeting malondialdehyde-modifications in rheumatoid arthritis regulate osteoclasts via inducing glycolysis and lipid biosynthesis","volume":"133","author":"Sakuraba","year":"2022","journal-title":"J Autoimmun"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104581","article-title":"Tylophorine-based compounds are therapeutic in rheumatoid arthritis by targeting the caprin-1 ribonucleoprotein complex and inhibiting expression of associated c-Myc and HIF-1\u03b1","volume":"152","author":"Lee","year":"2020","journal-title":"Pharmacol Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31472-1","article-title":"Pathogenetic insights from the treatment of rheumatoid arthritis","volume":"389","author":"McInnes","year":"2017","journal-title":"Lancet"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13228","article-title":"Altered metabolic pathways regulate synovial inflammation in rheumatoid arthritis","volume":"197","author":"Fearon","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2022-222370","article-title":"Interferon-&x3b1;-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming","volume":"81","author":"Cooles","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/art.41958","article-title":"Effect of JAK inhibition on the induction of proinflammatory HLA\u2013DR+CD90+ Rheumatoid arthritis synovial fibroblasts by interferon-\u03b3","volume":"74","author":"Zhao","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223396","article-title":"Cytokine-directed cellular cross-talk imprints synovial pathotypes in rheumatoid arthritis","volume":"82","author":"Kugler","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.779585","article-title":"Ferroptosis in rheumatoid arthritis: A potential therapeutic strategy","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex426","article-title":"Targeted inhibition of Janus kinases abates interfon gamma-induced invasive behaviour of fibroblast-like synoviocytes","volume":"57","author":"Karonitsch","year":"2018","journal-title":"Rheumatology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.221","article-title":"IFN\u03b3 drives synovial tissue remodelling","volume":"14","author":"McHugh","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s40744-023-00554-0","article-title":"The role of CCL3 in the pathogenesis of rheumatoid arthritis","volume":"10","author":"Yang","year":"2023","journal-title":"Rheumatol Ther"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201810_16137","article-title":"CCL3 participates in the development of rheumatoid arthritis by activating AKT","volume":"22","author":"Zhang","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e13807","DOI":"10.1111\/acel.13807","article-title":"The gut microbiota metabolite capsiate regulate SLC2A1 expression by targeting HIF-1\u03b1 to inhibit knee osteoarthritis-induced ferroptosis","volume":"22","author":"Guan","year":"2023","journal-title":"Aging Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1608262\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T12:13:50Z","timestamp":1752149630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1608262\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":43,"alternative-id":["10.3389\/fimmu.2025.1608262"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1608262","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"article-number":"1608262"}}